This compound is primarily utilized in the development of pharmaceuticals, particularly in the research and synthesis of anti-inflammatory and analgesic drugs. Its structure, featuring a fluorophenyl group and a methylsulfonylphenyl group, makes it a valuable intermediate in the creation of molecules that target cyclooxygenase (COX) enzymes, which are involved in inflammation and pain pathways. Additionally, it has potential applications in the study of neurodegenerative diseases, as its derivatives may influence pathways associated with neuroinflammation. Its cyclopentene core also offers versatility in medicinal chemistry for designing bioactive compounds with improved pharmacokinetic properties.